Growing community of inventors

Shanghai, China

Dawei Cui

Average Co-Inventor Count = 6.60

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 63

Dawei CuiZhenwei Cai (13 patents)Dawei CuiZhihua Sui (7 patents)Dawei CuiJeremy Mark Travins (7 patents)Dawei CuiJaneta Popovici-Muller (7 patents)Dawei CuiTao Liu (7 patents)Dawei CuiDing Zhou (7 patents)Dawei CuiRene Marc Lemieux (7 patents)Dawei CuiGiovanni Cianchetta (7 patents)Dawei CuiAnil Kumar Padyana (7 patents)Dawei CuiJingjing Ji (7 patents)Dawei CuiCharles Kung (2 patents)Dawei CuiTao Han (1 patent)Dawei CuiBinhua Lv (1 patent)Dawei CuiZelin Sheng (1 patent)Dawei CuiLianjun Liu (1 patent)Dawei CuiRunqing Wang (1 patent)Dawei CuiPeizhong Ni (1 patent)Dawei CuiZhenwei Cai (1 patent)Dawei CuiDawei Cui (15 patents)Zhenwei CaiZhenwei Cai (20 patents)Zhihua SuiZhihua Sui (108 patents)Jeremy Mark TravinsJeremy Mark Travins (52 patents)Janeta Popovici-MullerJaneta Popovici-Muller (45 patents)Tao LiuTao Liu (38 patents)Ding ZhouDing Zhou (22 patents)Rene Marc LemieuxRene Marc Lemieux (21 patents)Giovanni CianchettaGiovanni Cianchetta (21 patents)Anil Kumar PadyanaAnil Kumar Padyana (14 patents)Jingjing JiJingjing Ji (7 patents)Charles KungCharles Kung (3 patents)Tao HanTao Han (28 patents)Binhua LvBinhua Lv (21 patents)Zelin ShengZelin Sheng (4 patents)Lianjun LiuLianjun Liu (1 patent)Runqing WangRunqing Wang (1 patent)Peizhong NiPeizhong Ni (1 patent)Zhenwei CaiZhenwei Cai (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Agios Pharmaceuticals, Inc. (13 from 96 patents)

2. Servier Pharmaceuticals LLC (1 from 21 patents)

3. Suzhou Zelgen Biopharmaceuticals Co., Ltd. (1 from 7 patents)

4. Shanghai Zelgen Pharma.tech Co., Ltd. (1 from 1 patent)

5. Les Laboratoires Servier (290 patents)


15 patents:

1. 12133853 - Pyruvate kinase activators for use in treating blood disorders

2. 11957680 - Pyruvate kinase activators for use in treating blood disorders

3. 11872225 - Pyruvate kinase modulators and use thereof

4. 11667673 - Therapeutically active compounds and their methods of use

5. 11590132 - Pyruvate kinase activators for use in treating blood disorders

6. 11464775 - Pyruvate kinase modulators and use thereof

7. 11459327 - Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof

8. 11364240 - Pyruvate kinase activators for use in treating blood disorders

9. 11040036 - Pyruvate kinase activators for use in treating blood disorders

10. 11021515 - Therapeutically active compounds and their methods of use

11. 10717764 - Therapeutically active compounds and their methods of use

12. 10689414 - Therapeutically active compounds and their methods of use

13. 10640534 - Therapeutically active compositions and their methods of use

14. 9850277 - Therapeutically active compositions and their methods of use

15. 9474779 - Therapeutically active compositions and their methods of use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…